A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - Data from nationwide registries in Finland

Amyloid

Volumn 18, Issue 1, 2011, Pages 25-28

  Immonen, Kai ^a   Finne, Patrik ^b   Grönhagen Riska, Carola ^c   Pettersson, Tom ^c   Klaukka, Timo ^d   Kautiainen, Hannu ^e,f   Hakala, Markku ^g,h  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b Finnish Registry for Kidney Diseases   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

^e JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

AA amyloidosis; ankylosing spondylitis; dialysis; disease modifying anti rheumatic drug; kidney transplantation; outcome; renal disease; rheumatoid arthritis; uraemia

Indexed keywords

ADALIMUMAB; AUROTHIOMALATE; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; DRUG USE; FINLAND; HOSPITAL ADMISSION; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SOCIAL INSURANCE; UREMIA;

AMYLOIDOSIS; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; BIOLOGICAL THERAPY; FINLAND; HUMANS; KIDNEY FAILURE, CHRONIC; REGISTRIES; RENAL REPLACEMENT THERAPY; SPONDYLITIS, ANKYLOSING; UREMIA;

EID: 79751494989     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2010.549252     Document Type: Article

References (24)

1. Filipowicz-Sosnowska AM, Rostopowicz-Denisiewicz K, Rosentahl CJ, Baum J. The amyloidosis of juvenile rheumatoid arthritis-comparative studies in Polish and American children. I. Levels of serum SAA protein. Arthritis Rheum 1978;21:699-703. (Pubitemid 9121422)
2. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-49.
3. Kvalvik AG. Mortality in rheumatoid arthritis. Rheumatol Eur 1996;25:9-14.
4. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide-series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 1999;38:499-503. (Pubitemid 29504833)
5. Savolainen HA, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-1203. (Pubitemid 23278176)
6. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-176. (Pubitemid 23094303)
7. Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:107-114.
8. Immonen K, Savolainen A, Kautiainen H, Hakala M. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis. J Rheumatol 2008;35:907-912. (Pubitemid 351747136)
9. Kuroda T, Tanabe N, Harada T, Murakami S, Hasegawa H, Sakatsume M, Nakano M, Geiyo F. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2005;25:498-505.
10. Potyšová Z,Merta M, Tesař V, Jancová E, Honsová E, Ryšavá R. Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol 2009;41:941-945.
11. Hazenberg BPC, van Rijswijk MH. Where has secondary amyloidosis gone? Ann Rheum Dis 2000;59:577-579. (Pubitemid 30617081)
12. Immonen K, Finne P, HakalaM, Kautiainen H, Pettersson T, Grönhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases-data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334-1338. (Pubitemid 352000780)
13. Finne P, Reunanen A, Stenman S, Groop P-H, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;14:1782-1787. (Pubitemid 41434624)
14. Finnish Registry for Kidney Diseases Report 2008. Helsinki, Finland: Finnish Kidney Diseases; 2009. Available at: http:// www.musili.fi/smtr/english. Accessed January 12, 2011.
15. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18: 122-123. (Pubitemid 29223032)
16. Möttönen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-1573. (Pubitemid 29219206)
17. Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev- Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, et al. Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642-2651.
18. Tiitinen S, Myllykangas R, Helin H, Kaarela K. Modern trends in the diagnosis of secondary amyloidosis. Scand J Rheumatol Suppl 1988;67:30-31.
19. Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, et al. Anti-tumor necrosis factor a therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy. Arhritis Rheum 2003;48:2019-2024. (Pubitemid 36828697)
20. Falck HM, Maury CPJ, Teppo A-M,Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983;286:1391-1393. (Pubitemid 13128626)
21. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-29. (Pubitemid 32709735)
22. Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic amyloidosis. N Engl J Med 2007;356: 2361-2371. (Pubitemid 46883770)
23. Uda H, Yokota A, Kobayashi K, Miyake T, Fushimi H, Maeda A, Saiki O. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol 2006;33:1482-1487. (Pubitemid 44168816)
24. Koivuniemi R, Paimela L, Suomalainen R, Törnroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008;15:262-268.